Voyager Therapeutics (VYGR)
(Delayed Data from NSDQ)
$4.27 USD
-0.22 (-4.79%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $4.26 -0.01 (-0.23%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, Voyager Therapeutics, Inc. has a market cap of $248.78M, which represents its share price of $4.49 multiplied by its outstanding shares number of 55.47M. As a small-cap company, VYGR's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
VYGR 4.27 -0.22(-4.79%)
Will VYGR be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for VYGR based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for VYGR
Voyager Therapeutics (VYGR) Reports Q2 Loss, Lags Revenue Estimates
Voyager Therapeutics (VYGR) Reports Q1 Loss, Lags Revenue Estimates
VYGR: What are Zacks experts saying now?
Zacks Private Portfolio Services
Voyager Therapeutics (VYGR) Reports Q4 Loss, Misses Revenue Estimates
CytomX Therapeutics (CTMX) Tops Q4 Earnings and Revenue Estimates
TScan Therapeutics, Inc. (TCRX) Reports Q4 Loss, Lags Revenue Estimates
Other News for VYGR
Stochastic Reached Overbought appears for VYGR after 5.28% move
VYGR forms Shooting Star Candlestick on September 17
VYGR's price rises by 0.95% on September 16, though its technical setup remains stable.
Is VYGR poised for gains? 200 Day Moving Average Support shows up after rising 0.72%
VYGR Makes Notable Cross Below Critical Moving Average